Key points are not available for this paper at this time.
Design
Editorial
The authors suggest reappraising the potential role of digoxin in the treatment of heart failure, in light of observations on ivabradine and heart rate reduction.
This raises the question of whether the Cardiological community dismissed digoxin too readily and if we should reappraise its potential role in the treatment of heart failure.
No takes yet. Share an insight, caveat, or question.
Castagno et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: